LNTH

Lantheus Holdings, Inc.

78.83 USD
-1.25 (-1.56%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Lantheus Holdings, Inc. stock is down -0.97% since 30 days ago. The next earnings date is Aug 1, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 66.67% of the previous 9 June’s closed higher than May. In the last 10 Unusual Options Trades, there were 9 CALLs, 1 PUT.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
13 May 14:13 17 May, 2024 70.00 CALL 100 1071
14 May 14:10 18 Oct, 2024 72.50 CALL 74 98
14 May 14:31 17 May, 2024 77.50 CALL 150 288
14 May 14:49 17 Jan, 2025 72.50 CALL 41 21
20 May 15:51 21 Jun, 2024 82.50 PUT 100 48
20 May 19:03 21 Jun, 2024 70.00 CALL 50 95
23 May 18:33 18 Oct, 2024 72.50 CALL 26 99
28 May 15:13 19 Jul, 2024 82.50 CALL 100 79
04 Jun 14:40 18 Oct, 2024 72.50 CALL 29 127
12 Jun 17:19 18 Oct, 2024 75.00 CALL 31 153

About Lantheus Holdings, Inc.

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart. The company also offers AZEDRA, a radiotherapeutic to treat adult and pediatric patients; Automated Bone Scan Index that calculates disease burden of prostate cancer by quantifying the hotspots on bone scans.